Am J Transplant, Volume 20, Suppl 3 Archives - Page 91 of 223 - ATC Abstracts

2020 American Transplant Congress
Effect of Different Strategies to Decrease Post-Operative Opioid Use Following Living Donor Nephrectomy
D. Quan¹, J. Lazo², J. Lee³, A. Barnes⁴, S. Kang⁵
¹UCSF Medical Center, San Francisco, CA, ²Pharmaceutical Services, UCSF Medical Center, San Francisco, CA, ³School of Pharmacy, University of California San Francisco, San Francisco, CA, ⁴Department of Pharmaceutical Services, UCSF Medical Center, San Francisco, CA, ⁵Transplant Surgery, UCSF Medical Center, San Francisco, CA
*Purpose: Living donor transplant programs are essential in decreasing the number of kidney wait-list candidates, however, of utmost importance should be ensuring our donors are…
2020 American Transplant Congress
Choice of Mitral Valve and Aortic Valve for Replacement for ESRD Patients Eligible for Kidney Transplant: A USRDS Analysis
N. Sarabu¹, D. Ngendahimana², L. Al Dahabre³, K. Lentine⁴, K. Chavin¹, T. Srinivas¹, S. Deo²
¹University Hospitals Cleveland, Cleveland, OH, ²Case Western Reserve University, Cleveland, OH, ³University Hospitals of Cleveland, Cleveland, OH, ⁴Saint Louis University, Saint Louis, MO
*Purpose: Tissue valve (TiV) may be preferred over mechanical valve (meV) in ESRD patients for valve replacement. Among ESRD patients who are kidney transplant eligible,…
2020 American Transplant Congress
Are Molecular Diagnoses of Antibody Mediated Rejection (ABMR) Reliable in the Setting of Antibody-Antigen Complex Mediated Tissue Injury Unrelated to Alloimmunity?
P. Randhawa¹, Y. Huang¹, G. Tseng², K. Xiao³
¹University of Pittsburgh Medical Center, Pittsburgh, PA, ²Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, ³Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, Pittsburgh, PA
*Purpose: Transcriptomics based tests for ABMR are now available commercially. The reliability of these tests in clinical settings where allograft tissue is damaged by antibody-antigen…
2020 American Transplant Congress
Multi- National Survey among Nephrologists & Transplant Surgeons about the Suitability and Acceptance of the Marginal Live Kidney Donors Regarding Urological Issues
Z. Arabi¹, M. A. Bukhari², S. Kaysi³, A. R. Altheaby¹, E. A. Elhassan¹, A. A. Mateen¹, M. I. Abdalla¹, M. Gafar¹, S. A. Alam¹, N. Abdulmajeed⁴, A. Alkurdi⁵, A. Hamad⁶
¹KAMC, Riyadh, Saudi Arabia, ²Taif University, Taif, Saudi Arabia, ³CHU Clermont-Ferrand, Saint Pryv/ Saint Mesmin, France, ⁴PSMMC, Riyadh, Saudi Arabia, ⁵University of Toronto, Toronto, ON, Canada, ⁶The Regional Medical Center, Orangeburg, SC
*Purpose: Living donor kidney transplant is the primary modality of renal transplants in many countries. However, donors frequently present with some challenging conditions like some…
2020 American Transplant Congress
A Hybrid Data Envelopment Analysis-Artificial Neural Network (DEANN) Technique for Extrapolating the Evolution of Kidney Transplant Patients
F. Santos-Arteaga¹, D. Di Caprio², D. Cucchiari³, J. M. Campistol³, F. Oppenheimer³, F. Diekmann³, I. Revuelta³
¹Faculty of Economics and Management, Free University of Bolzano, Bolzano, Italy, ²Department of Economics and Management, University of Trento, Trento, Italy, ³Renal Transplant Unit, Department of Nephrology and Kidney Transplant, Hospital Clinic, Barcelona, Spain
*Purpose: The current study introduces a hybrid Data Envelopment Analysis (DEA) - Artificial Neural Network (ANN) technique to extrapolate the evolution of transplant patients based…
2020 American Transplant Congress
Treatment of De Novo Renal Transplant Recipients with Calcineurin Inhibitor (CNI)-Free, Belatacept+Everolimus-Based Immunosuppression
V. R. Peddi¹, B. Marder², L. Gaite³, J. Oberholzer⁴, R. Goldberg⁵, T. Pearson⁶, H. Yang⁷, L. Allamassey⁸, S. Gao⁸, M. Polinsky⁸, R. N. Formica⁹
¹California Pacific Medical Center, San Francisco, CA, ²Colorado Kidney Care, Denver, CO, ³Hospital Marqués de Valdecilla, Cantabria, Spain, ⁴UVA Health, Charlottesville, VA, ⁵Saint Barnabas Medical Center, Livingston, NJ, ⁶Emory University School of Medicine, Atlanta, GA, ⁷UPMC Pinnacle, Harrisburg, PA, ⁸Bristol-Myers Squibb, Princeton, NJ, ⁹Yale University School of Medicine, New Haven, CT
*Purpose: Compared with CNI-based immunosuppression, kidney transplant recipients receiving belatacept-based treatment present with a favorable metabolic profile, reduced chronic allograft nephropathy, and improved renal function,…
2020 American Transplant Congress
Liver Transplantation as a Salvage and Uncommon Procedure for a Patient with Colorectal Liver Metastsis with Promising Results, Case Presentation and Literature Review
M. Tabbal, M. Al Qahtani
Transplant Surgery, King Fahad Specialist Hospital Dammam, Dammam, Saudi Arabia
*Purpose: Colorectal cancer (CRC) is the third most common cancer worldwide. About 50% of patients with CRC will develop metastases during the course of the…
2020 American Transplant Congress
The Impact of Initial Alpha-Fetoprotein >100 but <1,000 ng/mL and Pre-Transplant alpha-Fetoprotein Reduction on Outcomes after Liver Transplant in Patients with Hepatocellular Carcinoma
M. L. Goldman¹, K. Zhou², J. L. Dodge¹, F. Yao¹, N. Mehta¹
¹Department of Medicine, UCSF, San Francisco, CA, ²Department of Medicine, USC, Los Angeles, CA
*Purpose: Under current UNOS policy, hepatocellular carcinoma (HCC) patients with alpha-fetoprotein (AFP) >1,000 ng/mL are required to show a reduction in AFP to 100 but
2020 American Transplant Congress
Split Liver Transplantation in a Combined Adult/Pediatric Transplant Program
J. Botha, R. Britz, J. Loveland, B. Strobele, S. Rambarran
School of Clinical Medicine, University of the Witwatersrand, Parktown, South Africa
*Purpose: Split liver transplantation (SLT) is an accepted surgical strategy to decrease waitlist mortality for pediatric recipients, concerns regarding increased morbidity right tri-segment graft (RTG)…
2020 American Transplant Congress
Correlation of CMV and EBV DNAemia in the Development of Invasive Fungal Disease among Pediatric Intestinal and Liver Transplant Recipients
B. M. Chatani¹, J. Garcia², T. Beduschi³, A. Tekin³, R. Vianna³, I. A. Gonzalez¹
¹Pediatric Infectious Disease, University of Miami Miller School of Medicine, Miami, FL, ²Pediatric Gastroenterology, University of Miami Miller School of Medicine, Miami, FL, ³Miami Transplant Institute, Miami, FL
*Purpose: Invasive fungal disease (IFD) among pediatric solid organ transplant recipients is a relatively rare event, however often results in death. There are many factors…